ArticleACS omega2019

Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma.

Asma Saqr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.